In the present study, we have shown that TAZ mRNA expression is positively correlated with two of its downstream targets, AXL and CTGF, and that TAZ is significantly associated with poor survival of colon cancer patients in two independent colon cancer datasets, comprising 522 patients. Here, AXL is linked to malignant colon neoplasm.